ReviewAsian journal of pharmaceutical sciences2020

Advances in nanotechnology-based delivery systems for EGFR tyrosine kinases inhibitors in cancer therapy.

Xiaohan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.